Blue Gold Ltd current report, Q3 FY2026

Blue Gold Limited — Form 6-K Summary

Reporting period: Form 6-K filed September 24, 2026, covering developments during September 2026. The filing reports leadership and governance changes, financing transactions, share restrictions, contractual amendments, litigation, and a deferred convertible-note payment.

Business Context and Reporting Period

Blue Gold Limited is a Cayman Islands foreign private issuer filing annual reports on Form 20-F. This filing does not provide operating or financial statements for the period.

Key Financial and Capitalization Matters

  • Private placement: On August 28, 2026, the Company entered into a private placement for an unsecured promissory note with original principal of up to $250,000 and detachable warrants.
  • Note terms: The note bears interest at 10% annually, with principal and accrued interest payable in cash on November 30, 2026. It is unsecured, unsubordinated, and pari passu with the Company’s other unsecured unsubordinated debt.
  • Warrants: Warrants are exercisable for Class A ordinary shares at $0.50 per share. The shares underlying each warrant equal 50% of the applicable subscription amount divided by $0.50, subject to adjustment.
  • Liquidity: The filing discloses near-term obligations, including repayment of the note on November 30, 2026 and a deferred payment to 3i, LP due October 5, 2026. It does not provide cash balances, revenue, profit, operating cash flow, margins, total debt, or available liquidity.
  • 3i convertible note: A payment due September 3, 2026 was deferred to October 5, 2026 in exchange for a $200,000 payment by the Company to 3i.
  • Facility conversion right: An amendment to the facility agreement with Kaela Ritchie gives the lender the right, but not the obligation, to convert all or part of the outstanding advance balance into Class A ordinary shares at $0.50 per share, subject to customary adjustments.
  • Restricted shares: The Board approved the unconditional release from lock-up of 3,683,749 remaining restricted shares.

Material Changes Versus the Prior Comparable Period

  • Kevin Clark became Executive Chairman effective September 17, 2026, succeeding Andrew Cavaghan.
  • Andrew Cavaghan resigned as Chairman, Chief Executive Officer, and director effective September 17, 2026. The filing states the resignation was not due to disagreement with the Company.
  • Gary Herman became a non-executive director and Audit Committee Chairman, replacing Tao Tan, effective September 17, 2026.
  • Tao Tan departed as director and Audit Committee Chairman effective September 17, 2026. The filing states his departure was not due to disagreement with the Company.
  • James Samuelson resigned as Chief Financial Officer effective September 18, 2026. The filing states the resignation was not due to disagreement with the Company.
  • Shah Nawaz was designated Chief Financial Officer effective September 17, 2026, and the Company engaged EMS Consulting Services, LLC for outsourced financial and accounting services.
  • The Board approved an amended and restated indemnification agreement expanding indemnification, expense advancement, and protections relating to personal guarantees for directors and officers.

Outlook, Risks, Contingencies, and Unusual Items

  • Cayman Islands litigation: Plaintiffs seek declarations regarding the status of certain Class A ordinary shares received in connection with the Perception Capital Corp. IV business combination. The Company believes the claim lacks merit and intends to defend and appeal.
  • On July 20, 2026, the Cayman Islands Court determined that the Plaintiffs’ relevant shares are unrestricted shares, found that required consent had not been obtained before calling the proposed extraordinary general meeting, and ordered the Company to remove applicable restrictions or legends. The injunction preventing a vote on the proposed Article 39 amendment remains in place pending further proceedings.
  • The Company paid $100,000 toward the Plaintiffs’ costs as ordered. Remaining claims and the Company’s counterclaim are pending.
  • The Company filed a Notice of Appeal on July 31, 2026 and sought a stay of the July 20 order. The filing does not state the ultimate outcome or quantify the potential loss; it describes a reasonable possibility of loss but says the amount or range cannot reasonably be estimated.
  • The promissory note contains default provisions, including nonpayment, covenant breaches, specified cross-defaults, bankruptcy or insolvency, and certain unsatisfied judgments. Upon default, holders may accelerate amounts due.
  • The note includes a most-favored-nation provision and restrictions on dividends, share repurchases, and other debt repayments while an event of default continues.
  • No revenue, earnings guidance, operating outlook, cash-flow forecast, or margin guidance is provided.

Most Important Facts for Investors to Verify

  • Whether the full $250,000 note principal was funded and the resulting warrant share count.
  • The Company’s cash balance and ability to meet the October 5, 2026 3i payment and November 30, 2026 note repayment.
  • The outstanding balance and conversion mechanics under the Kaela Ritchie facility agreement.
  • The potential dilution from the warrants, facility conversion right, and release of 3,683,749 restricted shares.
  • The status and financial implications of the Cayman Islands litigation, appeal, injunction, and counterclaim.
  • The terms and financial obligations under the transition and settlement agreements with Andrew Cavaghan and James Samuelson.
  • The effectiveness of the outsourced finance function and any effects on financial reporting, internal controls, or SEC filing compliance.